Propranolol in the treatment of angina pectoris. Comparison of duration of action in acute and sustained oral therapy.
1979; Lippincott Williams & Wilkins; Volume: 59; Issue: 3 Linguagem: Inglês
10.1161/01.cir.59.3.571
ISSN1524-4539
Autores Tópico(s)Statistical Methods in Clinical Trials
ResumoHomeCirculationVol. 59, No. 3Propranolol in the treatment of angina pectoris. Comparison of duration of action in acute and sustained oral therapy. Free AccessAbstractPDF/EPUBAboutView PDFSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessAbstractPDF/EPUBPropranolol in the treatment of angina pectoris. Comparison of duration of action in acute and sustained oral therapy. U Thadani and J O Parker U ThadaniU Thadani and J O ParkerJ O Parker Originally published1 Mar 1979https://doi.org/10.1161/01.CIR.59.3.571Circulation. 1979;59:571–579 Previous Back to top Next FiguresReferencesRelatedDetailsCited By Detry J, Sellier P, Pennaforte S, Cokkinos D, Dargie H and Mathes P (2012) Trimetazidine: a new concept in the treatment of angina. Comparison with propranolol in patients with stable angina. Trimetazidine European Multicenter Study Group., British Journal of Clinical Pharmacology, 10.1111/j.1365-2125.1994.tb04276.x, 37:3, (279-288), Online publication date: 1-Mar-1994. Donaldson K, Ayesu K, Francis J, Challenor V and Waller G (2009) Effects of Nifedipine and Propranolol on Whole Blood Platelet Aggregation, Platelets, 10.3109/09537109109006024, 2:3, (141-143), Online publication date: 1-Jan-1991. Kumana C (1987) Beta-adrenergic blocking drugs Drugs for Heart Disease, 10.1007/978-1-4899-3294-5_2, (29-75), . Schneeweiss A and Schettler G (1988) Propranolol Cardiovascular Drug Therapy in the Elderly, 10.1007/978-1-4613-2063-0_36, (305-327), . Pellinen T, Virtanen K, Valle M and Frick M (1986) Studies on ergometer exercise testing II. Effect of previous myocardial infarction, digoxin, and β-blockade on exercise electrocardiography, Clinical Cardiology, 10.1002/clc.4960091006, 9:10, (499-507), Online publication date: 1-Oct-1986. Guth B, Tajimi T, Seitelberger R, Lee J, Matsuzaki M and Ross J (1986) Experimental exercise-induced ischemia: Drug therapy can eliminate regional dysfunction and oxygen supply-demand imbalance, Journal of the American College of Cardiology, 10.1016/S0735-1097(86)80221-2, 7:5, (1036-1046), Online publication date: 1-May-1986. Walker P, Marshall A, Farr S, Bauminger B, Walters G and Barritt D (1985) Abrupt withdrawal of atenolol in patients with severe angina. Comparison with the effects of treatment., Heart, 10.1136/hrt.53.3.276, 53:3, (276-282), Online publication date: 1-Mar-1985. Thadani U (2009) Assessment of »Optimal» Beta Blockade in Treating Patients with Angina Pectoris, Acta Medica Scandinavica, 10.1111/j.0954-6820.1985.tb08813.x, 217:S694, (178-187) Matsuzaki M, Guth B, Tajimi T, Kemper W and Ross J (1985) Effect of the combination of diltiazem and atenolol on exercise-induced regional myocardial ischemia in conscious dogs., Circulation, 72:1, (233-243), Online publication date: 1-Jul-1985. Chaitman B, Wagniart P, Pasternac A, Brevers G, Scholl J, Lam J, Methe M, Ferguson R and Bourassa M (1984) Improved exercise tolerance after propranolol, diltiazem or nifedipine in angina pectoris: Comparison at 1, 3 and 8 hours and correlation with plasma drug concentration, The American Journal of Cardiology, 10.1016/0002-9149(84)90674-X, 53:1, (1-9), Online publication date: 1-Jan-1984. Mishriki A and Weidler D (2012) Long-Acting Propranolol ( Inderal LA ): Pharmacokinetics, Pharmacodynamics and Therapeutic Use , Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 10.1002/j.1875-9114.1983.tb03294.x, 3:6, (334-337), Online publication date: 12-Nov-1983. Frishman W and Kimmel B (2012) Commentary 2, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 10.1002/j.1875-9114.1983.tb03296.x, 3:6, (338-339), Online publication date: 12-Nov-1983. Snyder D and Sobel B (1983) Medical management of ischemic heart disease Cardiac therapy, 10.1007/978-1-4613-3855-0_15, (481-535), . Parker J (1983) Comparison of slow-release pindolol, standard pindolol, and propranolol in angina pectoris, The American Journal of Cardiology, 10.1016/0002-9149(83)90345-4, 51:7, (1062-1066), Online publication date: 1-Apr-1983. Bassan M and Weiler-Ravell D (1983) Effect of a twelve-hour hiatus in propranolol therapy on exercise tolerance in patients with angina pectoris, American Heart Journal, 10.1016/0002-8703(83)90520-3, 105:2, (234-238), Online publication date: 1-Feb-1983. Ishizaki T, Ohnishi A, Sasaki T, Chiba K, Suganuma T and Kushida K (1983) Concentration-effect and time-effect relationships of carteolol, European Journal of Clinical Pharmacology, 10.1007/BF00542514, 25:6, (749-757), . McGraw B (2017) Investigational Drug Information, Drug Intelligence & Clinical Pharmacy, 10.1177/106002808201600502, 16:5, (366-370), Online publication date: 1-May-1982. Packer M, Meller J, Medina N, Yushak M, Smith H, Holt J, Guererro J, Todd G, McAllister R and Gorlin R (1982) Hemodynamic consequences of combined beta-adrenergic and slow calcium channel blockade in man., Circulation, 65:4, (660-668), Online publication date: 1-Apr-1982.Parker J, Porter A and Parker J (1982) Propranolol in angina pectoris. Comparison of long-acting and standard-formulation propranolol., Circulation, 65:7, (1351-1355), Online publication date: 1-Jun-1982. Schwartz J, Jackson G, Kates R and Harrison D (1981) Long-term benefit of cardioselective beta blockade with once-daily atenolol therapy in angina pectoris, American Heart Journal, 10.1016/0002-8703(81)90125-3, 101:4, (380-385), Online publication date: 1-Apr-1981. MASSING G (1981) The Clinical Pharmacology of Antiarrhythmic Drugs Cardiac Pharmacology, 10.1016/B978-0-12-752050-6.50018-6, (305-332), . Olowoyeye J, Thadani U and Parker J (1981) Slow release oxprenolol in angina pectoris: Study comparing oxprenolol, once daily, with propranolol, four times daily, The American Journal of Cardiology, 10.1016/0002-9149(81)90223-X, 47:5, (1123-1127), Online publication date: 1-May-1981. Planz G and Planz R (1981) Dissociation between duration of plasma catecholamine and blood pressure responses to beta-adrenergic blockade in normotensive subjects during physical exercise, European Journal of Clinical Pharmacology, 10.1007/BF00568393, 19:2, (83-88), . Thadani U, Davidson C, Singleton W and Taylor S (1980) Comparison of five beta-adrenoreceptor antagonists with different ancillary properties during sustained twice daily therapy in angina pectoris, The American Journal of Medicine, 10.1016/0002-9343(80)90361-7, 68:2, (243-250), Online publication date: 1-Feb-1980. (1980) I. BETA-BLOCKING AGENTS, The Lancet, 10.1016/S0140-6736(80)92840-8, 315:8170, (693-698), Online publication date: 1-Mar-1980. Zelis R, Liedtke A and Flaim S (1980) Antianginal Drugs Clinical Applications of Cardiovascular Drugs, 10.1007/978-94-010-9178-7_4, (95-135), . Thadani U and Parker J (1980) Propranolol in angina pectoris: Comparison of therapy given two and four times daily, The American Journal of Cardiology, 10.1016/0002-9149(80)90613-X, 46:1, (117-123), Online publication date: 1-Jul-1980. Jackson G, Schwartz J, Kates R, Winchester M and Harrison D (1980) Atenolol: once-daily cardioselective beta blockade for angina pectoris., Circulation, 61:3, (555-560), Online publication date: 1-Mar-1980. March 1, 1979Vol 59, Issue 3 Advertisement Article InformationMetrics Copyright © 1979 by American Heart Associationhttps://doi.org/10.1161/01.CIR.59.3.571 Originally publishedMarch 1, 1979 PDF download Advertisement
Referência(s)